Long COVID: Pathophysiology, Symptoms, Treatment, and Management
A special issue of COVID (ISSN 2673-8112). This special issue belongs to the section "Long COVID and Post-Acute Sequelae".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 68
Special Issue Editors
Interests: long COVID; mobile health; symptom tracking; energy management; pacing
Special Issue Information
Dear Colleagues,
The symptoms of persistent coronavirus disease 2019 (COVID-19) are increasingly well reported in the literature. These persistent symptoms following acute infection, also known as ‘long COVID’, have affected people worldwide. Long COVID is a heterogeneous disease with multimorbidities affecting several physiological systems. Given the spread of the pandemic, the number of individuals suffering from long COVID is significant, currently estimated at over 100 million. Therefore, regularly collating high-quality research and innovative recovery solutions, covering several research areas, is crucial. Our aim in launching this Special Issue is to consider long COVID pathophysiology, symptomology, treatment strategies, and management strategies, aiming to guide the process from benchtop to bedside. Additionally, articles within this Special Issue will explore the socioeconomic impact of long COVID, the role of rehabilitation programs, and the effectiveness of emerging therapeutic approaches. A multidisciplinary perspective is essential in understanding the full scope of long COVID, as it affects not only physical health but also mental well-being, quality of life, and workforce participation.
Dr. Lawrence D. Hayes
Dr. Nilihan E.M. Sanal-Hayes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. COVID is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- long COVID
- pathobiological mechanisms
- cognitive and movement impairments
- symptomology
- energy management
- biomarkers
- genomics
- proteomics
- lipidomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
